Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
intimation of Analyst / Institutional Investor Conference call27-08-2020
27-08-2020
Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
intimation of Analyst / Institutional Investor Conference call26-08-2020
Buy Lasa Supergenerics; target of Rs 84: Khambatta Securities
Khambatta Securities is bullish on Lasa Supergenerics has recommended buy rating on the stock with a target price of Rs 84 in its research report dated August 25, 2020.26-08-2020
Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
An earnings conference call for analysts on Wednesday, 12th August 2020 @ 05:00 p.m to discuss the Company's Q1FY21 financial performance.10-08-2020
Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attached is the copy of Media Release titled ' LASA SUPERGENERICS Q1FY21 PAT AT 5.37CRS, UP437% YOY' issued by the company.06-08-2020
Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E. 05 August, 2020
The Board of Directors at its meeting held today which commenced at 11:30 am and concluded at 1:45 pm inter-alia considered and approved the following 1) Unaudited financial Result for the quarter ended June 30, 2020 along with Limited Review Report attached herewith. 2) Date and Time of 5th Annual General Meeting of the Company to be held through Video Conferencing (VC)/ other audio Visual Means (OAVM). 3) Notice of 5th Annual General Meeting along with Directors Report for the financial year 2019- 2020. 4) Appointment of Amit R. Dadheech & Associates, Practicing Company Secretaries to act as a Scrutinizer for 5th Annual General Meeting of the company05-08-2020
Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for The Quarter Ended June 30, 2020
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2020 ,inter alia, to consider and approve take on record Unaudited Financial Results along with the Limited Review Report of the Company for the quarter ended June 30, 2020 and/or to discuss any other business/matter with the permission of the Chair.27-07-2020
Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended June 30, 2020
Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here21-07-2020
Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nidhi KulshresthaDesignation :- Company Secretary and Compliance Officer15-07-2020
Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2020 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company.15-07-2020